LiverLearning®

Catalog Advanced Search

Search by Categories
Search in Packages
Search by Format
Search by Type
Search by Date Range
Products are filtered by different dates, depending on the combination of live and on-demand components that they contain, and on whether any live components are over or not.
Start
End
Search by Keyword
Sort By
  • Pediatric Liver Disorders SIG: Challenge of Fontan Associated Liver Disease

    Contains 8 Component(s) Recorded On: 11/09/2018

    AASLD's Pediatric Liver Disorders SIG: Challenge of Fontan Associated Liver Disease presented at The Liver Meeting® 2018.

    The hemodynamic changes in Fontan circulation (the palliative intervention in single ventricle physiology) confer risk of liver complications, particularly congestive hepatopathy. This program will include descriptions of the hepatopathy, the pathobiology of Fontan associated liver fibrosis, available diagnostic tools including imaging techniques and transplant-related medical decision making in the context of a failing Fontan.

    Veena Venkat

    Angela Lorts

    Elizabeth Rand

    Jonathan Dillman

    Vijay Shah

    John Magee

  • Career Development Workshop

    Contains 9 Component(s) Recorded On: 11/09/2018

    AASLD's Career Development Workshop presented at The Liver Meeting® 2018.

    This workshop will look at various training pathways for a career in hepatology. It will also describe various career opportunities in research, practice, education and industry, providing an overview of the rewards and challenges for each of these, and identify sources for research funding for fellows and junior faculty members.


    Oren K. Fix

    Valentina Medici

    Emily Rothbaum Perito

    Kathleen E. Corey

    Lawrence S. Friedman

    Dr. Lawrence S. Friedman attended Princeton University and received his undergraduate and medical degrees from the Johns Hopkins School of Medicine combined BA/MD program. He did his residency training at Johns Hopkins Hospital, followed by a clinical and research fellowship in gastroenterology at Harvard Medical School and Massachusetts General Hospital. He was on the faculty of Jefferson Medical College, where he served as Vice Chairman of the Department of Medicine and a member of the Gastrointestinal Unit at Massachusetts General Hospital. He is Professor of Medicine at Harvard Medical School and Tufts University School of Medicine. Since July 1, 2003, he has been Chair of the Department of Medicine at Newton-Wellesley Hospital and Assistant Chief of Medicine at Massachusetts General Hospital.

    Mark W. Russo

    Robert Myers

  • Non-alcoholic Fatty Liver Disease SIG: Advances in Genetics and Epigenetics in NAFLD: From Pathogenesis to Personalized Medicine

    Contains 7 Component(s) Recorded On: 11/09/2018

    AASLD's Non-alcoholic Fatty Liver Disease SIG: Advances in Genetics and Epigenetics in NAFLD: From Pathogenesis to Personalized Medicine presented at The Liver Meeting® 2018.

    This program will detail recent advances in the understanding of genetic and epigenetic alterations that influence NAFLD and its progression. It will emphasize their impact on the natural history of NAFLD and variability in clinical outcomes. Details on how patient based epigenetic association studies have led to novel insights into disease pathogenesis will be outlined with an emphasis on how this may translate to new therapeutics. Finally, the role of genetics and epigenetics in the evaluation of the patient in the clinic will be addressed – with particular reference to diagnosis, prognosis and therapeutics.

    Elizabeth Speliotes

    Christopher Glass

    Derek Mann

    Luca Valenti

  • Liver Transplantation and Surgery SIG & Surgery and Liver Transplantation Cmte: Combined Organ Transplants

    Contains 11 Component(s) Recorded On: 11/10/2018

    AASLD's Liver Transplantation and Surgery SIG & Surgery and Liver Transplantation Cmte: Combined Organ Transplants presented at The Liver Meeting® 2018.

    This program will review the current status of liver transplantation in the setting of combined organ transplants (i.e., liver/intestine/multi-visceral, liver/ kidney, liver/heart and liver/lung transplantation). Indications, pathophysiology, operative management, post-transplant care and outcomes will be discussed in the context of specific extra-hepatic organ dysfunction and combined organ transplantation. The session will also address the immunologic, ethical, financial and operational issues associated with multi-organ transplant as well as integration of these combined organ transplants in the overall liver allocation framework.

    Stuart Sweet

    Richard Shane Mangus

    Pratima Sharma

    Alex Wiseman

    Patrick S. Kamath

    Kim Olthoff

    Josh Levitsky

    Julie Heimbach

    John Fung

  • 2018 Clinical Hepatology Debrief

    Contains 2 Component(s) Recorded On: 11/13/2018

    AASLD's Clinical Hepatology Debrief presented at The Liver Meeting® 2018.

    This session provides a summary of the clinical highlights from The Liver Meeting®.

    Jorge A. Bezerra (Moderator)

    K. Rajender Reddy

  • 2018 Hepatitis Debrief

    Contains 2 Component(s) Recorded On: 11/13/2018

    AASLD's Hepatitis Debrief presented at The Liver Meeting® 2018.

    This session provides a synthesis of new data on the treatment of viral hepatitis presented at The Liver Meeting®.

    Jorge A. Bezerra (Moderator)

    Jordan J. Feld

  • Leon Schiff State-of-the-Art Lecture

    Contains 2 Component(s) Recorded On: 11/13/2018

    AASLD's Leon Schiff State-of-the-Art Lecture presented at The Liver Meeting® 2018.

    This lecture summarizes the current approach to understanding NASH pathogenesis, and how to translate recent advances into routine clinical care. Beginning with an overview of key pathogenic steps in development and progression of NASH, the program will also cover different therapeutic approaches for specific subsets of patients with NASH and related complications, and risk stratification of patients with respect to clinical outcomes.

    Michael W. Fried (Moderator)

    Arun J. Sanyal

  • 2018 NAFLD Debrief

    Contains 2 Component(s) Recorded On: 11/13/2018

    AASLD's NAFLD Debrief presented at The Liver Meeting® 2018.

    This session is designed to complement the highly-regarded, Hepatitis and Clinical Hepatology Debriefs, and will review key highlights from The Liver Meeting®.

    Jorge A. Bezerra (Moderator)

    Mary E. McCarthy Rinella

  • Hyman J. Zimmerman Hepatotoxicity State-of-the-Art Lecture

    Contains 2 Component(s) Recorded On: 11/12/2018

    AASLD's Hyman J. Zimmerman Hepatotoxicity State-of-the-Art Lecture presented at The Liver Meeting® 2018.

    Patients with underlying chronic liver disease (CLD) may develop drug-induced liver injury during clinical care or in clinical trials, and it is associated with poor outcomes. This lecture discusses medications and herbal agents that are commonly implicated in DILI, risk factors, strategies for  monitoring patients in clinical trials, guidelines for adjudicating suspected DILI events and outcomes associated with DILI in CLD.

    Raymond T. Chung (Moderator)

    Naga P. Chalasani

  • 2018 Advances for Practitioners

    Contains 5 Component(s) Recorded On: 11/12/2018

    AASLD's Advances for Practitioners presented at The Liver Meeting® 2018.

    This program reviews the most recent advances in the clinical management of patients with cirrhosis. Topics of discussion include the use of beta blockers, anticoagulants and albumin for managing different complications of cirrhosis. Additionally, the most updated recommendations regarding  screening issues for patients with cirrhosis will be reviewed.

    Michael B. Fallon

    Juan G. Abraldes

    Guadalupe Garcia-Tsao

    Dr. Garcia-Tsao is Professor of Medicine, Chief of Digestive Diseases and Program Director of the Hepatitis C Resource Center at Veteran’s Administration-Connecticut Healthcare System, as well as Director of Clinical and Translational Core at Yale Liver Center. She is a past president of AASLD. She received her M.D. and training at Universidad Nacional Autónoma de Mexico. Her primary research focus is on clinical research which focuses on cirrhosis and its complications, and she also is involved in the study of bacterial infections in cirrhosis, a complication that is often overlooked.

    Nicolas M. Intagliata